Archives for June 28, 2006

← 2006

Vertex provides update at Piper Jaffray conference

By  Wai Lang Chu

Vertex Pharmaceutcals was one of a number of pharma and biotech companies to attend the PiperJaffray healthcare conference in London last week, which gave international companies the opportunity to provide pipeline updates.

FFF Enterprises wins GSK flu contract

By  Kirsty Barnes

FFF Enterprises has just been awarded a new contract to distribute GlaxoSmithKline's (GSK's) flu vaccine in the US, making it the largest flu vaccine distributor for the second year running.

Lilly bails out on UK manufacturing plant

By  Gregory Roumeliotis

Determined to slash operational costs, Eli Lilly has decided to shut down its pill and tablet manufacturing plant in Basingstoke and boost production in its remaining three dry product sites.

PDS expand post-mortem software licensing options

By  Wai Lang Chu

Software provider, PDS Pathology Data Systems have announced it can now provide Internet access to its specialised post-mortem functionality system to users that include University research departments, CROs, Biotechs and smaller Toxicology and...

Cardinal Health bags insulin spray manufacturing deal

By  Kirsty Barnes

After launching its flagship oral insulin spray in Ecuador last December, Generex is finally gearing up to take on big pharma in the global non-injectable insulin arena and has picked Cardinal Health to help meet manufacturing demands.

Phase forward providing new CRO support

By  Kirsty Barnes

Data management solutions provider Phase Forward used the recent Drug Information Association (DIA) to unveil a new programme tailored to help clinical research organizations (CROs) of all sizes optimise their eClinical profitability.

Protherics' cash injection bodes well for biotechnology

By  Wai Lang Chu

BioPharmaceutical company Protherics, were on hand at the PiperJaffray conference providing pipeline and company updates to a audience of investors and analysts. The company are coming off the back of a successful deal with Astrazeneca for its CytoFab...

Novasep claims to be purer than pure

By  staff reporter

French purification specialist Novasep has unveiled a new series of preparative high-performance liquid chromatography (HPLC) columns that are ideally suited for the purification of any amount of product.

Cost emerges as major issue in Novartis RFID trial

By  Gregory Roumeliotis

A Dutch trial of battery-powered radiofrequency identification (RFID) tags in standard medication blister packages, sponsored by Novartis, has demonstrated the benefits the technology can have for patient compliance but also the prohibitive costs that...

New CRO on the Phase I scene

By  Kirsty Barnes

A new Phase I clinical services company, Roanoke Clinical Research (RCR), has been formed to relieve pressure in the biopharma industry as it continues to face bottlenecks in early stage research and struggles to move forward fast enough.